SGRYSurgery Partners, Inc.
What is the market doing?
No clear lean: insiders net buying, but heavily shorted (+11% of shares).
Choppy, but holding above its 200-day average. Overbought (RSI 83). Price is +9% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 22, 2026.
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 8.0% since the previous count, down from 11.6% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SGRY is trading
Surgery Partners, Inc. is −25% over the past year while the S&P 500 is +16%: 41 points behind the market. Through the fall, its own insiders bought $161K more stock than they sold.
1-year return · S&P 500 +16%
- vs 200-day average
- +9.1%
vs 200-day average · close to trend
- RSI (14)
- 83
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 31%
Below its 52-week high
Details›
- Last close2026-10-23
- $15.76
- 1 monthS&P 500 −0.94%
- +11%
- 1 yearS&P 500 +16%
- −25%
- 5 yearsS&P 500 +86%
- −58%
- vs 50-day average$14.25
- +11%
- 52-week high
- $22.94
- 52-week low
- $11.49
- Annualised volatility
- 49%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $161K
| Year | Return |
|---|---|
| 2026 (year to date) | +2.0% |
| 2025 | −27% |
| 2024 | −34% |
| 2023 | +15% |
| 2022 | −48% |
| 2021 | +84% |
| 2020 | +85% |
| 2019 | +60% |
| 2018 | −19% |
| 2017 | −24% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +13% |
| Feb | 10 | 7 of 10 | +4.6% |
| Mar | 10 | 4 of 10 | −8.3% |
| Apr | 10 | 4 of 10 | +6.9% |
| May | 10 | 6 of 10 | +2.7% |
| Jun | 10 | 4 of 10 | −0.90% |
| Jul | 11 | 5 of 11 | +3.5% |
| Aug | 11 | 5 of 11 | −6.2% |
| Sep | 11 | 5 of 11 | −1.5% |
| Oct | 11 | 4 of 11 | −4.1% |
| Nov | 10 | 7 of 10 | +9.8% |
| Dec | 10 | 5 of 10 | +3.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.